Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Hamostaseologie|January 30, 2020
Treatment of Vascular Thrombosis in Antiphospholipid Syndrome: An UpdateLida Kalmanti, Edelgard Lindhoff-LastHamostaseologie|November 2, 2022
Bleeding Issues in Women Under Oral AnticoagulationLida Kalmanti, Edelgard Lindhoff-LastCytotherapy|March 15, 2012
CD133 immunomagnetic separation: effectiveness of the method for CD133(+) isolation from umbilical cord bloodIordanis Pelagiadis, Konstantinos Relakis, Lida Kalmanti, et al.Leukemia Research|May 3, 2005
A morphometric approach for the evaluation of angiogenesis in acute lymphoblastic leukemia of childhoodLida Kalmanti, Konstantina Dampaki, Helen Dimitriou, et al.Cytotherapy|July 29, 2010
Comparative study of stemness characteristics of mesenchymal cells from bone marrow of children and adultsDespoina M Choumerianou, Georgia Martimianaki, Eftichia Stiakaki, et al.Annals of Hematology|March 25, 2014
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IVUlrike Proetel, Nadine Pletsch, Michael Lauseker, et al.Leukemia|May 9, 2020
High-risk additional chromosomal abnormalities at low blast counts herald death by CMLRüdiger Hehlmann, Astghik Voskanyan, Michael Lauseker, et al.Annals of Hematology|October 29, 2013
Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IVLida Kalmanti, Susanne Saussele, Michael Lauseker, et al.Leukemia|September 11, 2020
Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CMLRüdiger Hehlmann, Astghik Voskanyan, Michael Lauseker, et al.Blood|April 29, 2015
Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IVSusanne Saussele, Marie-Paloma Krauss, Rüdiger Hehlmann, et al.Pageof 2